Anti‐TNF‐alpha drugs ‐ moving into the mainstream?

Anti‐TNF drugs are a major treatment advance in the management of inflammatory disorders such as rheumatoid arthritis, and are typically considered following unsuccessful treatment with conventional disease‐modifying antirheumatic drugs (DMARDs). Drs Chris Deighton and Tina Ding review the available anti‐TNF‐alpha drugs, and consider their future place in therapy. Copyright © 2009 John Wiley & Sons, Ltd.